Key Takeaway
GLP-1 "microdosing" means staying on sub-therapeutic doses like 0.25 mg semaglutide long-term instead of escalating to the full weight-loss dose. Clinical trial data shows a clear dose-response relationship: lower doses produce less weight loss. No study has validated true microdosing (0.05-0.1 mg) for any outcome. Low-dose protocols may have a role in weight maintenance after goal weight is reached, but this remains unproven. Compounded semaglutide offers more dosing flexibility for clinicians who want to customize. Microdosing often uses compounded formulations; see Is Compounded Semaglutide Still Legal in 2026? What Patients Need to Know.
Open TikTok or Reddit and you will find people swearing by "microdosing" their GLP-1 medications. They stay on the 0.25 mg starting dose of semaglutide for months, or they split their doses to take tiny amounts several times a week. The claimed benefits: fewer side effects, steady weight loss, lower cost, and a gentler ride overall. Lower doses may reduce semaglutide side effects. Lower doses can reduce Semaglutide Cost Without Insurance: Complete Guide 2026.
The concept is appealing. But what does the actual clinical data say? The answer depends heavily on what you mean by "microdosing" and whether your goal is initial weight loss or long-term maintenance.
What Is GLP-1 Microdosing?
The term "microdosing" gets used loosely online, covering at least three different approaches that should be discussed separately.
| Approach | Typical Dose | Clinical Evidence |
|---|---|---|
| True microdosing (sub-standard doses) | 0.05-0.1 mg semaglutide weekly | None. No trials exist at these doses. |
| Low-dose maintenance (staying at starting dose) | 0.25-0.5 mg semaglutide weekly | Limited. The 0.25 mg dose was designed for titration only. |
| Reduced maintenance after goal weight | 0.5-1.0 mg semaglutide weekly | Some. STEP 2 tested 1.0 mg and showed 7% weight loss. |
The first category has zero clinical support. The second is untested for long-term use. The third has some basis in existing trial data, though it was not specifically designed for weight maintenance after reaching goal weight.[1]
What Does the Dose-Response Data Show for Semaglutide?
Weight loss with semaglutide is dose-dependent. Higher doses produce more weight loss. The clinical trial program makes this relationship clear.
In STEP 1, semaglutide 2.4 mg produced an average of 14.9% body weight loss over 68 weeks.[2] In STEP 2, which directly compared 2.4 mg and 1.0 mg in patients with type 2 diabetes, the results were 9.6% and 7.0% weight loss, respectively. Placebo produced 3.4%.[1]
The 0.25 mg starting dose was never tested as a standalone weight-loss dose. It was designed solely to give the gastrointestinal system time to adapt before escalation. The prescribing information for Wegovy is explicit: patients should increase to 0.5 mg after 4 weeks and continue escalating to the target dose of 2.4 mg.
This does not mean 0.25 mg does nothing. At any dose that reaches the GLP-1 receptors, some degree of receptor activation occurs. But the magnitude of that activation at 0.25 mg is a fraction of what happens at 2.4 mg. Expecting comparable weight loss from a dose that is 90% lower is not supported by the pharmacology.[3]
Why Are People Staying on Low Doses?
The reasons people choose low-dose protocols are understandable, even if the evidence does not fully support them.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Side effects. Nausea, vomiting, and diarrhea are the most common reasons people stop GLP-1 medications. These side effects are dose-dependent. Lower doses produce fewer GI problems for most people. If someone is losing weight at 0.5 mg with tolerable side effects, the motivation to escalate is low, especially if they have tried higher doses and felt miserable.
Cost. Brand-name semaglutide costs over $1,000 per month without insurance. Compounded semaglutide is far less expensive, and lower doses stretch the supply further. For someone paying out of pocket, staying on 0.25 or 0.5 mg cuts their monthly cost significantly.
Slower, more comfortable weight loss. Some people prefer losing 1-2 pounds per week over 3-4 pounds. Rapid weight loss can cause gallstones, loose skin, muscle loss, and fatigue. A slower pace may reduce these risks, though this has not been studied in a controlled comparison of different semaglutide doses.
Maintenance after goal weight. This is the most clinically defensible use of lower doses. Once someone has reached their target weight on a full dose, stepping down to a maintenance dose that prevents regain while reducing side effects and cost is a logical strategy. The question is which dose is sufficient.
Does Low-Dose Semaglutide Work for Weight Maintenance?
This is where the microdosing conversation gets more interesting. Maintaining weight loss requires less pharmacological support than achieving it. Once you are at goal weight, you do not need the same level of appetite suppression that drove the initial loss. You need enough to prevent the appetite rebound that causes regain. Microdosing is one strategy to prevent Ozempic Rebound: How Much Weight Do People Regain After Stopping GLP-1s?.
The STEP 1 extension data showed that stopping semaglutide entirely leads to ~67% regain within a year. A reduced maintenance dose could theoretically prevent most of that regain by keeping GLP-1 receptors partially activated.[4]
A mathematical model published in 2024 suggested that extending the dosing interval to every 2 weeks (effectively halving the dose) after reaching goal weight could preserve weight loss while reducing medication use. Some clinicians are already doing this in practice, though no large randomized trial has tested it.[5]
Anecdotally, many obesity medicine physicians report using a "step-down" approach: once a patient reaches goal weight at 2.4 mg, they reduce to 1.7 mg, then 1.0 mg, checking weight stability at each level. The lowest dose that holds weight stable becomes the maintenance dose. For some patients, that is 0.5 mg. For others, 1.0 mg is the floor below which weight creeps back up.
How Does Compounded Semaglutide Enable More Flexible Dosing?
Brand-name Ozempic and Wegovy come in fixed-dose pens with limited titration options. Compounded semaglutide, which is prepared by licensed 503A and 503B pharmacies, can be formulated at virtually any concentration. This gives prescribers and patients much more control over dosing.
With compounded formulations, a clinician can prescribe 0.3 mg, 0.4 mg, 0.6 mg, or any other dose that does not correspond to a standard pen click. This flexibility is useful for:
- Patients who experience side effects at standard dose jumps (e.g., nausea when going from 0.5 to 1.0 mg) and benefit from smaller increments
- Maintenance dosing at non-standard levels like 0.3 mg or 0.75 mg
- Every-other-week dosing at a higher per-injection dose to maintain convenience
- Patients who want to test different dose levels to find their minimum effective dose
FormBlends prescribes compounded semaglutide and tirzepatide with individualized dosing protocols. Our providers can work with you to find the right dose for your phase of treatment, whether that is initial weight loss or long-term maintenance.
What About Tirzepatide Microdosing?
Tirzepatide (Mounjaro/Zepbound) shows the same dose-response pattern. The SURMOUNT-1 trial tested 5 mg, 10 mg, and 15 mg doses, producing average weight losses of 15%, 19.5%, and 20.9% respectively. Lower doses produced less weight loss, though even the lowest dose of 5 mg outperformed semaglutide 2.4 mg in cross-trial comparisons.
The starting dose of 2.5 mg tirzepatide, like 0.25 mg semaglutide, is a titration dose. It is not designed for standalone use. But it does produce some GLP-1 and GIP receptor activation, and some people staying at 2.5-5.0 mg report meaningful appetite suppression and weight loss.
The same caveats apply: no trial has tested sub-therapeutic tirzepatide doses for weight loss or maintenance, and the dose-response relationship is clear.
What Are the Risks of GLP-1 Microdosing?
Using sub-therapeutic doses is not dangerous in the conventional sense. Semaglutide at 0.25 mg has the same side effect profile as at 2.4 mg, just milder. The risks are more about missed opportunity than direct harm:
- Undertreatment of obesity: If a low dose produces 3-4% weight loss instead of 15%, a patient with significant obesity may not reach the threshold (5-10% weight loss) where metabolic health benefits kick in
- False sense of progress: Slow weight loss on a low dose may stall entirely, leading to frustration and discontinuation
- No safety data: While low doses are unlikely to be harmful, the absence of clinical trials at microdose levels means unknown unknowns exist
- Cost without benefit: Even at lower costs per dose, spending months on a sub-therapeutic dose that produces minimal results is not a good use of money
What Should You Actually Do About Dosing?
The answer depends on where you are in your treatment journey.
If you are starting GLP-1 treatment for weight loss: Follow the standard dose escalation. The 0.25 mg starting dose is a stepping stone, not a destination. The clinical evidence for weight loss exists at 1.0 mg and above for semaglutide and 5.0 mg and above for tirzepatide. If side effects are limiting, work with your provider to slow the escalation rather than staying on a sub-therapeutic dose indefinitely.
If you have reached your goal weight: Talk to your provider about a step-down protocol. Gradually reducing your dose while monitoring weight stability is a reasonable approach. The minimum dose that maintains your results is your maintenance dose, and it may be lower than your peak dose.
If you cannot afford full-dose treatment: Compounded semaglutide at moderate doses (0.5-1.0 mg) is less expensive than brand-name Wegovy at 2.4 mg and will produce real, if more modest, weight loss. A moderate dose you can afford and sustain long-term is more useful than a full dose you can only take for a few months.
Frequently Asked Questions
Does 0.25 mg semaglutide cause weight loss?
The 0.25 mg dose was designed for GI adjustment during titration, not for standalone weight loss. Some people experience mild appetite suppression and small weight changes at this dose, but the clinical trials that demonstrated significant weight loss used doses of 1.0 mg and above.
Is GLP-1 microdosing safe?
Using lower-than-standard doses of semaglutide or tirzepatide is not expected to cause harm. The side effect profile is milder at lower doses. No clinical trial has studied true microdosing (sub-0.25 mg), so the safety and efficacy at those levels is unknown.
Can I stay on 0.5 mg semaglutide long-term instead of going up to 2.4 mg?
You can, but expect significantly less weight loss than at higher doses. The STEP 2 trial showed that 1.0 mg semaglutide produced about 7% weight loss versus 9.6% at 2.4 mg. Weight loss at 0.5 mg would be lower still. If your goal is modest and side effects are a concern, discuss a personalized plan with your provider.
Is microdosing GLP-1s just a TikTok trend?
The term "microdosing" is largely a social media creation. The underlying concept of personalized dosing is legitimate medicine. Clinicians have always adjusted medication doses based on individual response. The problem is when people self-prescribe sub-therapeutic doses without medical guidance, expecting results that the pharmacology does not support.
How much does GLP-1 microdosing save on costs?
If you are using compounded semaglutide, lower doses mean less medication per injection, which can reduce costs proportionally. With brand-name pens, savings depend on whether a lower-dose pen is available at a lower price. The most significant cost savings come from compounded formulations rather than from dose reduction alone.
What is the minimum effective dose of semaglutide for weight maintenance?
This has not been determined by clinical trials. In practice, many obesity medicine physicians use a step-down approach after patients reach goal weight, reducing the dose incrementally and monitoring for weight stability. The minimum effective maintenance dose varies by individual and may range from 0.5 mg to 1.7 mg weekly.
Does compounded semaglutide allow more flexible dosing?
Yes. Compounded semaglutide can be formulated at any concentration, allowing prescribers to set precise doses that do not correspond to standard pen increments. This flexibility is useful for slower titration, custom maintenance doses, and individualized protocols.
Should I microdose semaglutide to avoid side effects?
If side effects are limiting your treatment, work with your provider to slow the dose escalation rather than staying at a sub-therapeutic dose indefinitely. Smaller dose increments over a longer period often allow patients to reach therapeutic doses with manageable side effects.
Medical References
- Davies M, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021;397(10278):971-984. PMID: 33667417
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. PMID: 33567185
- Semaglutide for the treatment of overweight and obesity: A review. Eur J Pharmacol. 2023. PMC10092086
- Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564. PMID: 35441470
- One Size Does Not Fit All: Understanding Microdosing Semaglutide for Diabetes in Multidose Pens. Diabetes Care. 2025;48(3):e25. ADA Journals
- Jastreboff AM, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med. 2022;28(10):2083-2091. PMID: 36216945
This article is for educational purposes only and does not constitute medical advice. Do not adjust your medication dose without consulting your prescribing provider. FormBlends prescribes compounded semaglutide and tirzepatide through licensed telehealth consultations with individualized dosing protocols.
Reviewed by the FormBlends Medical Team. Last updated: 2026-04-10
Related guides
- Microdosing Semaglutide: Does Low-Dose GLP-1 Actually Work? (Glp1)
- What Is Microdosing Ozempic? Understanding Low-Dose Semaglutide Protocols
- Ozempic Microdosing Chart: A Complete Guide to Low-Dose Semaglutide Protocols
- What Does Microdosing Ozempic Mean? The Complete Guide to Low-Dose Semaglutide Protocols
- What Is Microdosing GLP-1, and Does It Actually Work?
- Microdose GLP-1: What the Science Says About Ultra-Low-Dose Semaglutide and Tirzepatide
- Tool: dosage calculator
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →